CYCLERION THERAPEUTICS Trademark

Trademark Overview

On Friday, September 7, 2018, a trademark application was filed for CYCLERION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CYCLERION THERAPEUTICS trademark a serial number of 88977803. The federal status of this trademark filing is REGISTERED as of Tuesday, June 30, 2020. This trademark is owned by Cyclerion Therapeutics, Inc.. The CYCLERION THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; conducting pharmaceutical clinical trials for others; pharmaceutical product development
cyclerion therapeutics

General Information

Serial Number88977803
Word MarkCYCLERION THERAPEUTICS
Filing DateFriday, September 7, 2018
Status700 - REGISTERED
Status DateTuesday, June 30, 2020
Registration Number6092732
Registration DateTuesday, June 30, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; conducting pharmaceutical clinical trials for others; pharmaceutical product development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 17, 2018
Primary Code042
First Use Anywhere DateMonday, March 18, 2019
First Use In Commerce DateMonday, March 18, 2019

Trademark Owner History

Party NameCyclerion Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameCyclerion Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameCyclerion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, February 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 30, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, May 26, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, May 23, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 13, 2020STATEMENT OF USE PROCESSING COMPLETE
Sunday, April 26, 2020USE AMENDMENT FILED
Wednesday, May 13, 2020DIVISIONAL PROCESSING COMPLETE
Sunday, April 26, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, May 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, April 26, 2020TEAS REQUEST TO DIVIDE RECEIVED
Sunday, April 26, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 16, 2019EXAMINER'S AMENDMENT ENTERED
Monday, December 16, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2019EXAMINERS AMENDMENT E-MAILED
Monday, December 16, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 9, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 9, 2019FINAL REFUSAL E-MAILED
Tuesday, July 9, 2019FINAL REFUSAL WRITTEN
Tuesday, June 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 25, 2019ASSIGNED TO LIE
Wednesday, June 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 20, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 20, 2018NON-FINAL ACTION E-MAILED
Thursday, December 20, 2018NON-FINAL ACTION WRITTEN
Tuesday, December 18, 2018ASSIGNED TO EXAMINER
Monday, September 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 11, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics cyclerion pharmaceutical development others product trials conducting research clinical